Similar articles

• The value of level III clearance in patients with axillary and sentinel node positive breast cancer.

  Dillon MF, Advani V, Masterson C, O'Loughlin C, Quinn CM, O'Higgins N, Evoy D, McDermott EW. Dillon MF, et al. Ann Surg. 2009 May;249(5):834-9. doi: 10.1097/SLA.0b013e3181a40821. Ann Surg. 2009. PMID: 19387317
• Can radiotherapy replace axillary dissection for patients with positive sentinel nodes?

  Recht A. Recht A. Breast Dis. 2010;31(2):91-7. doi: 10.3233/BD-2010-0295. Breast Dis. 2010. PMID: 21368371
• Axillary nodal yields: a comparison between primary clearance and completion clearance after sentinel lymph node biopsy in the management of breast cancer.

  Chakravorty A, Sanmugalingam N, Shrestha A, Thomee E, Rusby J, Roche N, MacNeill F. Chakravorty A, et al. Eur J Surg Oncol. 2011 Feb;37(2):122-6. doi: 10.1016/j.ejso.2010.10.005. Epub 2010 Nov 20. Eur J Surg Oncol. 2011. PMID: 21095094
• Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

  Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F. Gipponi M, et al. J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022. J Surg Oncol. 2004. PMID: 14991881 Review.
• Management strategy of early-stage breast cancer patients with a positive sentinel lymph node: With or without axillary lymph node dissection.

  Chen JJ, Wu J. Chen JJ, et al. Crit Rev Oncol Hematol. 2011 Sep;79(3):293-301. doi: 10.1016/j.critrevonc.2010.06.008. Epub 2010 Jul 21. Crit Rev Oncol Hematol. 2011. PMID: 20663684 Review.